Article Information
History
- September 23, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sohyun Hwang1,2,#,
- Jaejoon Lim3,#,
- Haeyoun Kang1,
- Ju-Yeon Jeong2,
- Je-Gun Joung2,4,
- Jinhyung Heo1,
- Daun Jung1,
- Kyunggi Cho3,§ and
- Hee Jung An1,2,§
- 1Department of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
- 2CHA Future Medicine Research Institute, CHA Bundang Medical Center, Seongnam, Korea
- 3Department of Neurosurgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
- 4Department of Biomedical Science, CHA University, Seongnam, Korea
- ↵§These two authors contributed equally to this work as co-corresponding authors. Corresponding authors Hee Jung An, MD PhD
, Department of Pathology, CHA Bundang Medical Center, 59 Yatap-ro, Bundang-gu, Seongnam-si, Korea, 13496, Telephone: +82-31-780-5440, Fax: +82-31-780-5045, e-mail: hjahn{at}cha.ac.kr, Kyunggi Cho, MD PhD
, Department of Neurosurgery, CHA Bundang Medical Center, 59 Yatap-ro, Bundang-gu, Seongnam-si, Korea, 13496, Telephone: +82-31-780-5688, Fax: +82-31-780-5269, e-mail: sandori50{at}gmail.com
↵# These two authors contributed equally to this work as co-first authors.
Posted September 23, 2022.
Predictive Biomarkers for the Responsiveness of Recurrent Glioblastomas to Activated Killer Cell Immunotherapy
